Moteur de recherche d’entreprises européennes
Financement britannique (251 512 £) : Un système d’analyse par cytométrie en flux multiparamétrique à la pointe de la technologie pour la recherche multidisciplinaire sur les cellules souches Ukri 01/04/2007 Recherche et innovation du Royaume-Uni, Royaume Uni
Vue d’ensemble
Texte
Un système d’analyse par cytométrie en flux multiparamétrique à la pointe de la technologie pour la recherche multidisciplinaire sur les cellules souches
| Abstract | Stem cells are capable of essentially extensive growth whilst retaining the ability to differentiate into most of the cell types found in the adult but unless we can find ways to grow them in large numbers while directing them to differentiate into therapeutically useful cells much of this potential will not be realised. A major obstacle impacting the derivation of differentiated cell types from stem cells is that current in vitro differentiation strategies often only produced the desired cells in small numbers. This means they must be separated from the other cell types present and one of the best techniques we have for doing this is flow cytometry. This technology relies upon the binding of fluorescent labelled antibodies to the surfaces of our desired cells such that when they pass through the flow cytometer they can be separated from the others and retain their viability. If appropriate antibodies are available, up to 12 different colours can be analysed at any one time using the instrumentation detailed in this proposal and this offers us an unparalleled advantage in cell identification and separation. There are a number of active research groups at the Institute of Human Genetics investigating a range of differentiation protocols designed to produce useful cells from a range of stem cells and flow cytometry instrumentation is not only indispensable to this work but is also subject to very heavy demand. In view of this, a successful outcome of this proposal would greatly enhance our ability to develop useful techniques for stem cell differentiation that will ultimately benefit medical science in general. |
| Category | Research Grant |
| Reference | BB/E012841/1 |
| Status | Closed |
| Funded period start | 01/04/2007 |
| Funded period end | 31/03/2008 |
| Funded value | £251 512,00 |
| Source | https://gtr.ukri.org/projects?ref=BB%2FE012841%2F1 |
Participating Organisations
| Newcastle University | |
| Inova Technology | |
| BD Biosciences |
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Newcastle University, Newcastle Upon Tyne, Royaume Uni.
